A.L. Sarroff Fund, LLC bought $401K of PetVivo (PETV)

Executed Apr 9 2024, disclosed Jan 16, 647 days later, against a two-business-day limit.

Value, as filed

$401K

561,168 sh across 2 lots

Executed

Apr 9 2024

the trade date, as filed

Disclosed

Jan 16

647 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

-28.7%

+0.1% from execution

Over the 21 trading sessions from the disclosed entry session (Jan 16), the stock returned -28.7% (delay-adjusted); from the execution session (Apr 9 2024), +0.1%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

AL A.L. Sarroff Fund, LLC 10% owner profile →

A.L. Sarroff Fund, LLC (10% owner) filed 5 Form 4 reports as a reporting entity in the trailing twelve months (5 purchases, 0 sales, 2 filed past the two-business-day deadline), most often in PetVivo Holdings, Inc. (PETV). Across 5 priced purchase filings, the average 21-session return was +11.8% from execution and -8.2% from disclosure (delay-adjusted; derived). The largest single filing was $1.0M of PETV (as filed), executed Mar 13.

The name

PETV

PetVivo Holdings, Inc. PETV · Healthcare · 5 filings in 24 months ticker →

Healthcare · PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animal…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by A.L. Sarroff Fund, LLC in PETV

PETVPURCHASE PetVivo Holdings, Inc. $150K
as filed
Exec Jun 9
Filed Jun 11 · 4:08 PM ET PETVPURCHASE PetVivo Holdings, Inc. $100K
250,000 sh × $0.40
Exec May 22
Filed May 26 · 4:18 PM ET PETVPURCHASE PetVivo Holdings, Inc. $1.0M
as filed
Exec Mar 13
Filed Mar 13 · 5:10 PM ET PETVPURCHASE PetVivo Holdings, Inc. $100K
111,112 sh × $0.90
Exec Dec 15 2023
Filed Jan 16 · 4:37 PM ET †